Related Experiment Video
Updated: May 23, 2025

05:07
Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
928
Angiography-Derived Microcirculatory Resistance in Detecting Microvascular Obstruction and Predicting Heart Failure
Guanyu Lu1, Lei Zhao2, Keyao Hui1
1Department of Interventional Diagnosis and Treatment (G.L., K.H., Z.L., X.M.), Beijing Anzhen Hospital, Capital Medical University, China.
Circulation. Cardiovascular Imaging
|April 3, 2025
Summary
Angiography-derived microcirculatory resistance (AMR) effectively detects microvascular obstruction (MVO) after heart attacks. This measure also independently predicts heart failure (HF) risk in ST-elevation myocardial infarction patients.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Interventional Cardiology
Background:
- Microvascular obstruction (MVO) is a known complication of ST-segment-elevation myocardial infarction (STEMI) that contributes to heart failure (HF).
- Assessing microvascular function early is crucial for patient outcomes.
- Angiography-derived microcirculatory resistance (AMR) offers a novel, wire- and adenosine-free method for evaluating microvascular function post-intervention.
Purpose of the Study:
- To evaluate the diagnostic capability of AMR in detecting MVO.
- To assess the prognostic value of AMR for predicting new-onset HF in STEMI patients undergoing primary percutaneous coronary intervention (PCI).
Main Methods:
- Retrospective review of 475 STEMI patients who underwent primary PCI and cardiac magnetic resonance (CMR) between April 2016 and February 2023.
- AMR was calculated from coronary angiography data.
- MVO was identified and quantified using CMR; new-onset HF was the primary endpoint during follow-up.
Main Results:
- AMR demonstrated good performance in detecting MVO, with an area under the curve of 0.821 and an optimal cutoff of 2.7 mm Hg*s/cm.
- During a median follow-up of 37.3 months, 25.5% of patients developed HF.
- AMR was an independent predictor of HF, both as a continuous and categorical variable, even after adjusting for traditional risk factors and CMR parameters. It significantly improved prognostication.
Conclusions:
- AMR is a valuable tool for diagnosing MVO in STEMI patients post-PCI.
- AMR serves as an independent and incremental predictor of HF, enhancing risk stratification beyond conventional methods.

